Hot Features
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company’s product c... Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company’s product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.24 | -3.02648171501 | 7.93 | 8.463 | 7.485 | 77408 | 7.99828872 | CS |
| 4 | -1.48 | -16.1395856052 | 9.17 | 9.68 | 7 | 72962 | 8.23142727 | CS |
| 12 | -3.99 | -34.1609589041 | 11.68 | 14.98 | 7 | 61996 | 9.83580183 | CS |
| 26 | 2.04 | 36.1061946903 | 5.65 | 14.98 | 5.0301 | 54289 | 8.86785706 | CS |
| 52 | 5.75 | 296.391752577 | 1.94 | 16.34 | 1.74 | 100289 | 7.1885503 | CS |
| 156 | 6.01 | 357.738095238 | 1.68 | 16.34 | 0.8981 | 75006 | 4.57612152 | CS |
| 260 | 3.63 | 89.4088669951 | 4.06 | 16.34 | 0.8311 | 51014 | 4.47546692 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.